|
WHAT'S THIS?
|
PRESS RELEASES << Global Publisher Informa Healthcare to Launch First Open-Access Journal
|
Global Publisher Informa Healthcare to Launch First Open-Access Journal
Published 8 June 2010
New Journal to Offer Rapid Publication of Specialized Interest Research
LONDON - June 8, 2010 – Informa Healthcare announced today that it will be launching
its first open-access journal, the Journal of Drug Assessment (JDA). The online,
peer-reviewed journal will focus on the rapid publication of specialized interest research,
including inconclusive and negative clinical trial results. The journal will be launched
this autumn.
“Regulatory requirements are changing, and pharmaceutical companies are facing pressure
to publish all clinical trial data. Traditionally, journals have focused on the publication of
conclusive trial results,” explained Publisher Jay Magrann. “This journal’s mission is
to channel the specialized interest research that may otherwise be excluded by
many journals’ selection policies to physicians and the public alike.”
JDA will be part of a new journal series with Current Medical Research & Opinion (CMRO)
and the Journal of Medical Economics (JME). Like its sister titles, JDA will offer rapid
and rigorously peer-reviewed publication of clinical trial data.
JDA will join Informa Healthcare’s portfolio of over 170 journals, including CMRO,
the Expert Opinion series, the Critical Review series, Leukemia and Lymphoma,
Clinical Toxicology, and society journals including Harvard Review of Psychiatry,
Acta Oncologica and British Journal of Neurosurgery.
More information and updates are available on informahealthcare.com/jda.
About Informa Healthcare
Informa Healthcare provides authoritative research and analysis for all sectors of the Life Science,
Medicine and Pharmaceutical sectors to better serve the commercial and academic needs within
the scientific and clinical communities. Informa Healthcare is a division of Informa plc (London: INF).
Informa has more than 150 offices in 40 countries and employs 7,500 staff around the world.
Informa Healthcare is headquartered in London with offices in New York, Melbourne, Singapore and
Stockholm.
For more information, visit: http://www.informahealthcare.com
About Current Medical Research & Opinion
CMRO is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication
of original research on new and existing drugs and therapies, Phase II-IV studies, and
post-marketing investigations. Its mission is to provide ethical, unbiased and rapid publication
of quality content that is validated by rigorous peer review and serves the information needs
of the clinical medicine community. As a member of the Committee on Publication Ethics (COPE),
the journal takes an active role in supporting Good Publication Practice and advancing
transparency in publication.
For more information, visit: http://www.cmrojournal.com/
About Journal of Medical Economics
JME is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication
of high-quality economic assessments of novel therapeutic and device interventions. Its mission
is to provide ethical, unbiased and rapid publication of quality content that is validated by
rigorous peer review and to serve the information needs of the pharmacoeconomics
and healthcare research community. As a member of the Committee on Publication Ethics (COPE),
the journal takes an active role in supporting Good Publication Practice and advancing transparency
in publication.
For more information, visit: http://informahealthcare.com/loi/jme.
|
Feedback: Do you have any comments about this article? Contact the Publisher, Peter Llewellyn.
|
|
|
